Weight change in actual practice: Three month results from the Schizophrenia Outpatient Health Outcomes (SOHO) study

被引：0
|
作者：
Edgell, ET
Frewer, P
Haro, JM
Novick, D
Wright, P
机构：
[1] Eli Lilly & Co, Windlesham, Surrey, England
[2] Ctr Salut Mental Gava, St Joan De Deu SSM, Barcelona, Spain
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2002年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A43
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [31] Remission and relapse in the outpatient care of schizophrenia -: Three-year results from the Schizophrenia Outpatient Health Outcomes Study
    Maria Haro, Josep
    Novick, Diego
    Suarez, David
    Alonso, Jordi
    Pierre Lepine, Jean
    Ratcliffe, Mark
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (06) : 571 - 578
  • [32] Long-term patterns of antipsychotic treatment of outpatients with schizophrenia: 36-month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
    Treuer, Tamas
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : A13 - A13
  • [33] Long-term patterns of antipsychotic treatment of outpatients with schizophrenia: 24-Month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
    Bitter, I.
    Treuer, T.
    Dyachkova, Y.
    West, T.
    Martenyi, F.
    McBride, M.
    Ungvari, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S150 - S150
  • [34] The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Hong, Jihyung
    Windmeijer, Frank
    Novick, Diego
    Maria Haro, Josep
    Brown, Jacqueline
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (05): : 835 - 841
  • [35] Effectiveness of different doses of olanzapine in outpatients with schizophrenia: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D.
    Deberdt, W.
    Haro, J. M.
    Suarez, D.
    Guerreiro, M.
    Laranjeira, L.
    Edlund, C.
    Marques-Teixeira, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S280 - S280
  • [36] ADHERENCE WITH ANTIPSYCHOTIC TREATMENT MEDICATION IN OUTPATIENTS WITH SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SCHIZOPHRENIA OUTPATIENTS HEALTH OUTCOMES (SOHO) STUDY
    Novick, D.
    Suarez, D.
    Haro, J. M.
    Haddad, P. M.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [37] Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Gasquet, I
    Haro, JM
    Novick, D
    Edgell, ET
    Kennedy, L
    Lepine, JP
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 199 - 205
  • [38] Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
    Dossenbach, Martin
    Dyachkova, Yulia
    Pirildar, Sebnem
    Anders, Martin
    Khalil, Afaf
    Araszkiewicz, Aleksander
    Shakhnovich, Tamara
    Akram, Aly
    Pecenak, Jan
    McBride, Margaret
    Treuer, Tamas
    EUROPEAN PSYCHIATRY, 2006, 21 (04) : 251 - 258
  • [39] Clinical status and tolerability profiles of previously untreated schizophrenia patients. 24-month results from the pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Novick, D
    Haro, JM
    Belger, M
    Tzivelekis, S
    Lepine, JP
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Mavreas, V
    Murray, D
    Naber, D
    Pancheri, P
    Slooff, CJ
    Texeira, JM
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 498 - 499
  • [40] Clinical status and tolerability profiles of previously untreated schizophrenia patients. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Novick, D
    Haro, JM
    Belger, M
    Tzivelekis, S
    Lepine, JP
    Bushe, C
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
12345